CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma. [electronic resource]
Producer: 20131210Description: 925-33 p. digitalISSN:- 1523-6536
- Aged
- Antibodies, Bispecific -- therapeutic use
- Antigens, CD20 -- genetics
- Antineoplastic Agents -- therapeutic use
- CD3 Complex -- genetics
- Cell Proliferation
- Cytokines -- biosynthesis
- Cytotoxicity, Immunologic
- Female
- Gene Expression
- Hematopoietic Stem Cell Transplantation
- Humans
- Killer Cells, Natural -- immunology
- Lymphoma, Non-Hodgkin -- immunology
- Middle Aged
- T-Lymphocytes -- immunology
- Transplantation, Autologous
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.